Raymond James Financial
SANA icon

Raymond James Financial’s Sana Biotechnology SANA Stock Holding History

Raymond James Financial’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$105K Sell
36,407
-2,866
-7% -$11.3K ﹤0.01% 5028
2025
Q4 		$160K Buy
+39,273
New +$176K ﹤0.01% 4839
2025
Q3 		– Sell
-477
Closed -$1.3K – 6422
2025
Q2 		$1.3K Buy
+477
New +$984 ﹤0.01% 6513

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

Raymond James Financial's SANA Position: Q1 2026 in Review

Raymond James Financial reduced its Sana Biotechnology (SANA) stake by 7.3% in Q1 2026, selling an estimated $11.3K and leaving 36,407 shares worth $105K. The position accounts for ﹤0.01% of the portfolio, ranked #5028.

Raymond James Financial first reported a position in SANA in Q2 2025 and has held it in 3 quarters since. The position peaked at $160K in Q4 2025. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

  • Raymond James Financial held 36,407 shares of Sana Biotechnology worth $105K as of Q1 2026.
  • Raymond James Financial sold 2,866 Sana Biotechnology shares in Q1 2026, an estimated $11.3K.
  • Sana Biotechnology made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #5028 holding.
  • Raymond James Financial first reported a position in Sana Biotechnology in Q2 2025 and has held it in 3 quarters since.
  • Raymond James Financial's Sana Biotechnology position peaked at $160K in Q4 2025.
  • 202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.